LONG MINI FUTURE WARRANT - NOVO-NORDISK B Stock

Certificat

9JE3H

DE000GZ3ACR6

Market Closed - Euronext Paris 12:30:02 2022-11-25 pm EST
25.79 EUR +1.30% Intraday chart for LONG MINI FUTURE WARRANT - NOVO-NORDISK B

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Goldman Sachs
9JE3H
ISINDE000GZ3ACR6
Date issued 2022-11-15
Strike 347.2 kr
Maturity Unlimited
Parity 0.5 : 1
Emission price 22.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 25.79
Lowest since issue 20.65
Spread -0.29
Spread %1.14%

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
980.3 DKK
Average target price
956.5 DKK
Spread / Average Target
-2.43%
Consensus
  1. Stock Market
  2. Certificates
  3. 9JE3H Certificat